0001209191-21-018736.txt : 20210308 0001209191-21-018736.hdr.sgml : 20210308 20210308185721 ACCESSION NUMBER: 0001209191-21-018736 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210305 FILED AS OF DATE: 20210308 DATE AS OF CHANGE: 20210308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GAROFALO ELIZABETH A. CENTRAL INDEX KEY: 0001826361 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39011 FILM NUMBER: 21723524 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 12830 EL CAMINO REAL, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXICURE, INC. CENTRAL INDEX KEY: 0001698530 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 815333008 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2430 N. HALSTED ST. CITY: CHICAGO STATE: IL ZIP: 60614 BUSINESS PHONE: 847-673-1700 MAIL ADDRESS: STREET 1: 2430 N. HALSTED ST. CITY: CHICAGO STATE: IL ZIP: 60614 FORMER COMPANY: FORMER CONFORMED NAME: Max-1 Acquisition Corp DATE OF NAME CHANGE: 20170221 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-05 0 0001698530 EXICURE, INC. XCUR 0001826361 GAROFALO ELIZABETH A. C/O EXICURE, INC. 2430 N. HALSTED ST. CHICAGO IL 60614 1 0 0 0 Stock Option (right to buy) 2.06 2021-03-05 4 A 0 100000 0.00 A 2031-03-04 Common Stock 100000 100000 D The shares subject to the option vest in 36 substantially equal monthly installments from the vesting commencement date of March 5, 2021, subject to the Reporting Person's continued service through the applicable vesting date. /s/ David Giljohann, Attorney-in-Fact 2021-03-08